Emergent BioSolutions' (EBS) CEO Dan Abdun-Nabi on Q3 2017 Results - Earnings Call Transcript

11/6/17

Emergent BioSolutions Inc. (NYSE:EBS)

Q3 2017 Earnings Conference Call

November 02, 2017, 05:00 PM ET

Executives

Bob Burrows – Vice President-Investor Relations

Dan Abdun-Nabi – President and Chief Executive Officer

Bob Kramer – Executive Vice President and Chief Financial Officer

Analysts

Yuko Oku – JPMorgan

Keay Nakae – Chardan

Laura Christianson – Cowen

Lisa Springer – Singular Research

François Brisebois – Laidlaw

Operator

Good day, ladies and gentlemen, and welcome to the Q3 2017 Emergent BioSolutions Earnings Conference Call. At this time all participants are in a listen-only mode. Later we will conduct a question-and-answer session and instructions will follow that time. [Operator Instructions]

I would now like to turn the call over to the company. Please go ahead.

READ FULL ARTICLE HERE

It's on us. Share your news here.

Submit your stories and articles to citybizlist today.

Baltimore Business Spotlight

Feature Your Business Here

Connect with these Baltimore Professionals on LinkedIn

  • Edwin Warfield

    Editor in Chief, Warfield Digital

    Connect
  • Jean Halle

    Independent Consultant

    Connect
  • Larry Lichtenauer

    President of Lawrence Howard & Associates

    Connect
  • Newt Fowler

    Partner at Womble Carlyle, LLP

    Connect
  • David Crowley

    Owner at Develop DC

    Connect
  • Carolyn Stinson

    Stinson Marketing Group

    Connect